These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35058547)
1. Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers. Anderson EL; Williams DM; Walker VM; Davies NM Sci Rep; 2022 Jan; 12(1):1057. PubMed ID: 35058547 [TBL] [Abstract][Full Text] [Related]
2. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Bell RD; Winkler EA; Singh I; Sagare AP; Deane R; Wu Z; Holtzman DM; Betsholtz C; Armulik A; Sallstrom J; Berk BC; Zlokovic BV Nature; 2012 May; 485(7399):512-6. PubMed ID: 22622580 [TBL] [Abstract][Full Text] [Related]
4. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756 [TBL] [Abstract][Full Text] [Related]
13. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status. Reas ET; Triebswetter C; Banks SJ; McEvoy LK Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861 [TBL] [Abstract][Full Text] [Related]
14. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative. Dunk MM; Driscoll I; J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023 [TBL] [Abstract][Full Text] [Related]
15. Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer's Disease Trajectory? Femminella GD; Taylor-Davies G; Scott J; Edison P; J Alzheimers Dis; 2018; 64(3):981-993. PubMed ID: 29966204 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis. Cao J; Huang M; Guo L; Zhu L; Hou J; Zhang L; Pero A; Ng S; El Gaamouch F; Elder G; Sano M; Goate A; Tcw J; Haroutunian V; Zhang B; Cai D Mol Psychiatry; 2021 Sep; 26(9):4687-4701. PubMed ID: 32632205 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment. Sanabria-Diaz G; Demonet JF; Rodriguez-Herreros B; Draganski B; Kherif F; Melie-Garcia L Neuroimage Clin; 2021; 32():102799. PubMed ID: 34469849 [TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of cyclophilin a and matrix metalloproteinase-9 are associated with cognitive impairment in patients with obstructive sleep apnea. Li M; Sun H; Shen T; Xue S; Zhao Y; Leng B; Zhang J; Li Z; Xia Z Sleep Med; 2022 May; 93():75-83. PubMed ID: 34857483 [TBL] [Abstract][Full Text] [Related]
19. Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials. Kennedy RE; Cutter GR; Wang G; Schneider LS J Alzheimers Dis; 2016; 50(4):1205-15. PubMed ID: 26836180 [TBL] [Abstract][Full Text] [Related]
20. Plasma MMP-9 Levels as the Future Risk of Conversion to Dementia in ApoE4-Positive MCI Patients: Investigation Based on the Alzheimer's Disease Neuroimaging Initiative Database. Abe K; Chiba Y; Ide K; Yoshimi A; Asami T; Suda A; Odawara T; Hishimoto A J Prev Alzheimers Dis; 2022; 9(2):331-337. PubMed ID: 35543007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]